Cadent Therapeutics to Present at the Jefferies Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement and cognitive disorders, today announced that Jodie Morrison, the Company’s Chief Executive Officer, will present at the Jefferies Healthcare Conference on Tuesday, June 4, 2019 at 10:00 am ET in New York City.
About Cadent Therapeutics
Cadent Therapeutics is creating breakthrough therapies for the treatment of movement disorders and cognitive impairment. The company combines target specificity, patient selection, drug design and optimization, and novel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders. Cadent Therapeutics is rapidly advancing its pipeline of positive allosteric modulators to treat spinocerebellar ataxia, essential tremor and schizophrenia. The company has an exclusive license and collaboration agreement with Novartis to develop a negative allosteric modulator, now in Phase 1 clinical studies for the treatment of treatment resistant depression. Investors include Atlas Venture, Cowen Healthcare Investments, Qiming Venture Partners, Access Industries, Clal Biotechnology Industries, Novartis Institutes for Biomedical Research and Slater Technology Fund. For more information, please visit cadenttx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190528005073/en/
Investors:
Maeve Conneighton, [email protected]
212.600.1902
Media:
David
Rosen, [email protected]
212.600.1902
Source: Cadent Therapeutics
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crypto Update: Pepeto Stage Sells Out at Record Speed While the Solana Price Prediction Targets $336 and Meme Coin Season Stars
- Award-Winning Educator Jacqueline H. Faber Introduces Newly Republished Editions of Her Imaginative Children’s Books While Looking Ahead to Her Next Adventure
- Nebius Group announces pricing of upsized private offering of $5.0 billion of convertible senior notes
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Jefferies & Co, Atlas Venture, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share